Japan Tissue Engineering Co., Ltd. provided earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥2,540 million, operating loss of ¥389 million and net loss of ¥388 million or ¥9.57 per share.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
596 JPY | +4.38% | -4.33% | +17.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.79% | 149M | |
+11.28% | 127B | |
-4.91% | 11.32B | |
+3.22% | 9.04B | |
+38.32% | 5.56B | |
-23.02% | 4.72B | |
+8.52% | 3.45B | |
-7.27% | 2.86B | |
-6.99% | 2.07B | |
-13.32% | 2.04B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023